Applicants should hold a PhD in Synthetic Organic Chemistry and/or MD, and have postdoctoral research experience in the area of hematology/oncology research, specifically in the development of small molecule PROTAC degraders for Target Protein Degradation. Evidence of scholarly ability (i.e., record of publications in peer-reviewed journals, acquisition of external funding, and presentation experience) is expected.